Inhaled Aroxxen to protect the heart during stent placement
Part of Heart & circulation clinical trials.
This trial tests whether an inhaled medication called Aroxxen® can protect your heart during a planned stent procedure. It may help reduce stress on the heart muscle.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 80 years old.
- You have a planned (non-emergency) stent placement for a blocked heart artery.
- You have stable angina or a history of heart damage without current heart attack symptoms.
- Your heart damage marker (troponin) level is normal before the procedure.
- You are willing to follow all study visits and procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who need a coronary (heart) stent to see how they do after treatment. It does not sound like an experimental drug trial for you—it’s mainly about collecting health information after a stent procedure.
This trial tests a new stem cell treatment (HeXell-2020) for people with stable coronary artery disease. It aims to see if it's safe and can improve heart function. You may be eligible if you have stable angina and are on regular heart medications.
This study looks at how well doctors can treat multiple blocked heart arteries using a specific drug-eluting stent, aiming to fully open them. It may help patients whose blockage pattern fits the study, but it does not include certain high-risk or special cases.
This study tests a new kind of coronary stent that slowly releases rapamycin to keep an artery open. You may be invited if you have a small number of specific, treatable blockages and can take the required blood-thinning medicines.
This Phase 4 study tests a way to measure blood flow in heart arteries to help doctors choose the best stent plan. It may help improve safety and effectiveness for people having elective heart stent procedures for stable angina or certain heart attacks.
This study compares two ways of guiding a heart stent procedure: using information from a special angiography scan versus using standard practice. It may help your care team choose the best treatment to improve heart outcomes after stenting.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.